中国生物制药(01177.HK)组件营养类产品"素乾"获特殊医学用途配方食品注册证
格隆汇 4 月 28日丨中国生物制药(01177.HK))宣布,集团的组件营养类产品"素乾"(特殊医学用途碳水化合物组件配方食品)已通过国家市场监督管理总局的注册审批,获颁发特殊医学用途配方食品注册证。该产品主要成分为碳水化合物12.5g/100ml,适用於18岁以上择期手术术前需要补充碳水化合物和水的人群。
素乾是国内最早上市的口服碳水化合物(CHO)制剂,是基于加速康复外科(ERAS)理念而研发,为针对择期手术患者术前使用的标准化口服碳水化合物产品,为中华医学会外科学分会、中华医学会麻醉学分会的《加速康复外科中国专家共识及路径管理指南(2018版)》推荐使用。其作用包括:(1)增加患者术前能量储备,减少术后并发症的发生;(2)术前预补充患者能量和水分,减少术中集中大量补液带来的术後伤口癒合迟缓;(3)显著缓解患者手术前的口渴、饥饿、焦虑等主观不适,提高手术耐受力。
集团始终秉持健康大众、惠泽天下的理念,在坚持开发尖端创新药和生物药的同时,致力于推动ERAS理念在国内的发展和实践,战略性开拓特医食品市场。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.